Tactile Systems Technology Inc
Research Tactile Systems Technology Inc (TCMD) on Bullrun: valuation model: 6.0% undervalued, market cap USD 509.41M, P/E 20.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTCMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal6.0% undervalued
- Market capUSD 509.41M
- P/E20.7
- Financial periodQ2 2026
- RevenueUSD 85.70M
- Net incomeUSD 7.79M
- Free cash flowUSD 1.94M
- Gross margin76.3%
Valuation Snapshot
Bullrun's latest valuation model marks Tactile Systems Technology Inc as 6.0% undervalued; latest market cap is USD 509.41M; P/E is 20.7.
Peer valuation comparison
Latest P/E is 20.67x versus a Healthcare sector median of 24.64x (16.1% below).
Latest P/E is 20.67x versus a United States median of 23.85x (13.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 329.52M | USD 19.09M | USD 40.43M | 75.9% | 0.82 | USD 83.45M | USD 0 | USD 218.90M |
| FY2024 | USD 292.98M | USD 16.96M | USD 38.26M | 74.0% | 0.7 | USD 94.37M | USD 45.11M | USD 216.60M |
| FY2023 | USD 274.42M | USD 28.52M | USD 33.53M | 71.1% | 1.23 | USD 61.03M | USD 50.38M | USD 193.64M |
| FY2022 | USD 246.79M | -USD 17.87M | USD 3.43M | 71.3% | -0.89 | USD 21.93M | USD 72.23M | USD 121.40M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 509.41M | 20.7 | n/a | n/a |
| 2025 | 2025-12-31 | USD 650.73M | 34.5 | n/a | n/a |
| 2024 | 2024-12-31 | USD 409.12M | 24.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 336.02M | 13.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 231.38M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 378.27M | n/a | n/a | n/a |
About Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Tactile Systems Technology Inc overvalued or undervalued?
Bullrun's valuation model currently marks Tactile Systems Technology Inc as 6.0% undervalued.
What is Tactile Systems Technology Inc's market cap?
Tactile Systems Technology Inc's market capitalization is USD 509.41M.
What is Tactile Systems Technology Inc's P/E ratio?
Tactile Systems Technology Inc's price-to-earnings (P/E) ratio is 20.7.
What does Tactile Systems Technology Inc do?
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.